Cargando…
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis
BACKGROUND: Trans-arterial radio-embolization (TARE) is an emerging treatment for the management of hepatocellular carcinoma (HCC). TARE may compete with systemic chemotherapy, sorafenib, in intermediate stage patients with prior chemoembolization failure or advanced patients with tumoral macrovascu...
Autores principales: | Rognoni, Carla, Ciani, Oriana, Sommariva, Silvia, Bargellini, Irene, Bhoori, Sherrie, Cioni, Roberto, Facciorusso, Antonio, Golfieri, Rita, Gramenzi, Annagiulia, Mazzaferro, Vincenzo, Mosconi, Cristina, Ponziani, Francesca, Sacco, Rodolfo, Trevisani, Franco, Tarricone, Rosanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034232/ https://www.ncbi.nlm.nih.gov/pubmed/29976149 http://dx.doi.org/10.1186/s12885-018-4636-7 |
Ejemplares similares
-
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses
por: Rognoni, Carla, et al.
Publicado: (2016) -
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study
por: Mosconi, Cristina, et al.
Publicado: (2016) -
Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020) -
Update of the Bologna Experience in Radioembolization of Intrahepatic
cholangiocarcinoma
por: Mosconi, Cristina, et al.
Publicado: (2023) -
Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analyses
por: Rognoni, Carla, et al.
Publicado: (2017)